Emerging Drug Trends

DEA is closely monitoring the emerging threats of novel synthetic opioids. Illicit drugs have always been dangerous, but today’s supply has reached unprecedented levels with the emergence of potent synthetic opioids.

Law enforcement and public health officials are seeing fentanyl combined with highly potent substances such as xylazine, nitazenes, cychlorphine, and medetomidine. Many of these substances are not approved for human use and are often undetectable to the user.

Why This Matters:

Extreme Potency: These emerging synthetic drugs can be significantly more powerful than fentanyl and greatly increase the risk of suffering a fatal overdose.
Hidden Mixtures: These substances are frequently mixed into counterfeit pills or fentanyl powder without the user’s knowledge.
Reduced Reversal Effectiveness: Drugs like xylazine and medetomidine are not opioids, meaning naloxone may not fully reverse their effects, complicating overdose response. Other synthetics, such as nitazenes and cychlorphine, might require several doses of naloxone to be effective.
Severe Health Impacts: Xylazine has been linked to devastating soft tissue damage, infections, and prolonged sedation, while other synthetics can cause rapid respiratory depression and death.

Public Safety Guidance:

Never take a pill that wasn’t prescribed to you and dispensed by a licensed pharmacy.
Assume all illicit drugs may contain fentanyl or other deadly additives.
Carry naloxone and be trained in how to use it but understand it may not fully reverse all substances present.
Call 911 immediately in any suspected drug poisoning or overdose. Time is critical.
Stay informed and spread awareness. This threat is evolving rapidly.